- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Amanda J. Klingler
News 4 results
Cases & Deals
May 23, 2024
King & Spalding Secures Victory for Boehringer Ingelheim in First Zantac-Related Trial
Recognition
September 8, 2023
LMG Life Sciences Honors King & Spalding as its Government Investigations Firm of the Year and Non-IP Impact Case of Year – United States
Cases & Deals
December 7, 2022
King & Spalding Helps Get Thousands of Claims Dismissed in Zantac MDL
Press Release
November 3, 2016
King & Spalding Elects 14 New Partners Across Seven Offices
Events 13 results
Conference
May 15, 2024
Annual King & Spalding California Life Sciences Summit
Webinar
March 29, 2024
The Machines Are Coming (And Lawsuits Too): Mitigating Risks of Product Design, Manufacture, and Sale Amidst the AI Revolution
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
September 7, 2023
King & Spalding’s Cross-Disciplinary Life Sciences Team to Present on AI at the 16th Annual Medical Device Summit
Insights 14 results
Client Alert
Client Alert
March 25, 2024
FDA Publishes White Paper on Artificial Intelligence & Medical Products
Client Alert
December 19, 2023
The Administration Takes Aim At Drug Prices Again – This Time Through A Controversial Framework for Exercising March-In Rights
Feature
December 12, 2023
General Counsel’s Decision Tree for Internal Investigations for the Life Sciences Industry